OptimizeRx Corp. said on Monday it appointed Troy Sarich as a company advisor, adding a veteran with nearly three decades of experience in healthcare, life sciences and pharmaceutical commercialization.
Sarich, who previously served as Chief Commercial Data Science Officer at Johnson & Johnson, will support OptimizeRx’s technology and data offerings, focusing on evaluating and implementing data analytic solutions aimed at improving patient and commercial outcomes. His appointment follows the company’s efforts to enhance its data-driven tools for life sciences marketers.
OptimizeRx, headquartered in Waltham, Massachusetts, provides healthcare technology solutions designed to help life sciences companies reach healthcare professionals and patients. The company’s platforms leverage data and digital engagement to support commercial decision-making in the pharmaceutical sector.
Stephen Silvestro, OptimizeRx’s Chief Executive Officer, said Sarich’s expertise in data, artificial intelligence and digital technologies aligns with the company’s mission to deliver scalable solutions for life sciences brands.
Sarich, whose background includes roles in research and development and commercial organizations, has worked on the clinical development and commercialization of medicines across cardiology, oncology, immunology and neuroscience. His prior role at Johnson & Johnson involved preparing the Innovative Medicine business for data-driven, AI-enabled healthcare.
In a statement, Sarich said OptimizeRx has led its industry by equipping life sciences marketers with solutions that harness data to improve commercial decision-making and audience engagement. He added that he looks forward to helping guide the company’s momentum amid evolving needs of brands, patients and providers.
